ZFP64 and hepatocellular carcinoma: Interestingly, when resminostat (1 μmol/l) was added subsequent to infections with MeV-SCD (employing adjusted MOIs), again lower zfp64 mRNA expression levels were observed in all three hepatoma cell lines when being compared to untreated controls (Figure 5, purple bars).